Bayer AG
XETRA:BAYN
Bayer AG
Total Liabilities & Equity
Bayer AG
Total Liabilities & Equity Peer Comparison
Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors
Company | Total Liabilities & Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Bayer AG
XETRA:BAYN
|
Total Liabilities & Equity
€116.3B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
9%
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Total Liabilities & Equity
$293.5m
|
CAGR 3-Years
38%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Merck KGaA
XETRA:MRK
|
Total Liabilities & Equity
€48.5B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
9%
|
|
MPH Health Care AG
XETRA:93M1
|
Total Liabilities & Equity
€198m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Dermapharm Holding SE
XETRA:DMP
|
Total Liabilities & Equity
€2.2B
|
CAGR 3-Years
21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Total Liabilities & Equity
€129.1m
|
CAGR 3-Years
8%
|
CAGR 5-Years
9%
|
CAGR 10-Years
N/A
|
See Also
What is Bayer AG's Total Liabilities & Equity?
Total Liabilities & Equity
116.3B
EUR
Based on the financial report for Dec 31, 2023, Bayer AG's Total Liabilities & Equity amounts to 116.3B EUR.
What is Bayer AG's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
9%
Over the last year, the Total Liabilities & Equity growth was -7%.